Analgesics in South Korea
The pandemic encouraged many local consumers to limit the number of visits to the doctor in 2020/2021, especially those suffering from minor symptoms. As such, this led to a decline for Rx prescription analgesics, a factor which boosted OTC sales during these years. However, overall retail volume sales of adult analgesics is predicted to decline in 2022, whilst remaining above pre-pandemic levels. Furthermore, the shortage of Rx acetaminophen products was evident in South Korea for more than two...
Euromonitor International's Analgesics in South Korea report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
- Analgesics in South Korea
- Euromonitor International
- October 2022
- List Of Contents And Tables
- ANALGESICS IN SOUTH KOREA
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Unstable supply of acetaminophen, demand for Tylenol remains popular
- Pharmaceutical companies operating at 100% production capacity
- Solid growth for topical analgesics/anaesthetic driven by wide usage occasions
- PROSPECTS AND OPPORTUNITIES
- Demand for topical analgesics, including pain relief patches, to remain strong
- Further declines for systemic analgesics over forecast period
- Tylenol is expected to remain strong as many local consumers avoid biosimilar drugs
- CATEGORY DATA
- Table 1 Sales of Analgesics by Category: Value 2017-2022
- Table 2 Sales of Analgesics by Category: % Value Growth 2017-2022
- Table 3 NBO Company Shares of Analgesics: % Value 2018-2022
- Table 4 LBN Brand Shares of Analgesics: % Value 2019-2022
- Table 5 Forecast Sales of Analgesics by Category: Value 2022-2027
- Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2022-2027
- CONSUMER HEALTH IN SOUTH KOREA
- EXECUTIVE SUMMARY
- Consumer health in 2022: The big picture
- 2022 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
- Table 8 Life Expectancy at Birth 2017-2022
- MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2017-2022
- Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
- Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
- Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
- Table 13 Distribution of Consumer Health by Format: % Value 2017-2022
- Table 14 Distribution of Consumer Health by Format and Category: % Value 2022
- Table 15 Forecast Sales of Consumer Health by Category: Value 2022-2027
- Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- Summary 1 OTC: Switches 2021-2022
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 2 Research Sources
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook